Medication Guide and Prescribing Information | REMS | Healthcare Professionals

HomeAbout
AMPYRA®		Talking to Your
Healthcare Provider		Newly
Prescribed		Already Taking
AMPYRA®		Care PartnersAMPYRA®
Events

Paying For Medication Isn't Always Easy

Help & Support When You Need It

Acorda Therapeutics, Inc. the maker of AMPYRA® (dalfampridine) Extended Release Tablets, is committed to making AMPYRA affordable and accessible to as many people as possible.

AMPYRA Patient Support Services and Co-Pay Program

If you are prescribed AMPYRA, AMPYRA Patient Support Services will confirm your insurance and your eligibility for the co-pay program. This program is for people with private insurance, where allowed by law. If you are eligible, you may not pay more than $40 per month for AMPYRA.

What If I Can't Afford AMPYRA?

There is a program designed to help people who have limited income and little or no insurance for AMPYRA. IF you are prescribed AMPYRA, and cannot afford the cost, the patient assistance team will work with you through a simple application process to see if you are eligible to receive AMPYRA at no cost. Contact AMPYRA Patient Support Services to learn more.

Acorda Therapeutics is committed to protecting your privacy. Any of the information you share with us regarding the AMPYRA Patient Assistance Program will not be sold or used for any marketing solicitations by Acorda or any of its affiliates.

Call AMPYRA Patient Support Services toll-free at 1-888-881-1918 Monday through Friday, from 8 am to 8 pm ET.

Next: Safety and Side Effects
Questions? 1-888-881-1918

Already taking AMPYRA? Sign up for AMPYRA Connect:

  • Tips on taking AMPYRA
  • Comprehensive AMPYRA information and updates
  • How to prepare for your doctor visits
  • Tracking and monitoring your progress
  • Ongoing support tools
Sign up now

If you're still trying to determine whether AMPYRA might be right for you, you can sign up to receive additional information.

AMPYRA® (dalfampridine) Extended Release Tablets is indicated as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

Important Safety Information

Do not take AMPYRA if you:

  • have ever had a seizure
  • have certain types of kidney problems

Do not take AMPYRA together with other aminopyridine medications, including compounded 4-AP (sometimes called 4-aminopyridine, fampridine).

AMPYRA can cause seizures. Your chance of having a seizure is higher if you take too much AMPYRA or if you have kidney problems. Before taking AMPYRA tell your doctor if you have kidney problems. Stop taking AMPYRA and call your doctor right away if you have a seizure while taking AMPYRA.

AMPYRA may cause serious side effects, including kidney or bladder infections.

The most common side effects of AMPYRA include: urinary tract infection; trouble sleeping (insomnia); dizziness; headache; nausea; weakness; back pain; problems with balance; multiple sclerosis relapse; burning, tingling or itching of your skin; irritation in your nose and throat; constipation; indigestion; pain in your throat.

Take AMPYRA exactly as your doctor tells you to take it. Do not change your dose of AMPYRA.

Take one tablet of AMPYRA 2 times each day about 12 hours apart. Do not take more than 2 tablets of AMPYRA in a 24-hour period.

Take AMPYRA tablets whole. Do not break, crush, chew or dissolve AMPYRA tablets before swallowing. AMPYRA is released slowly over time. If the tablet is broken, the medicine may be released too fast. This can raise your chance of having a seizure.

If you miss a dose of AMPYRA, do not make up the missed dose. Do not take 2 doses at the same time. Take your next dose at your regular scheduled time. If you take too much AMPYRA, call your doctor or go to the nearest hospital emergency room right away.

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if AMPYRA will harm your unborn baby.

Tell your doctor if you are breast-feeding or plan to breast-feed. It is not known if AMPYRA passes into your breast milk. You should not breast-feed while you are on AMPYRA.

It is not known if AMPYRA is safe and effective in children less than 18 years of age.

For more information, please see the complete Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Patient Medication Guide| Prescribing Information| Contact Acorda| Sitemap| References| Privacy Policy| Terms of Use
AMPYRA® is a registered trademark of Acorda Therapeutics®, Inc. | AMPYRA® is marketed by Acorda Therapeutics®, Inc and manufactured under license from Alkermes Pharma Ireland Ltd. | AMPYRAConnect™ is a trademark of Acorda Therapeutics®, Inc. | The Walking Pill™ is a trademark of Acorda Therapeutics®, Inc. | Take the next step™ is a trademark of Acorda Therapeutics®, Inc. | © 2011 Acorda Therapeutics®, Inc. All rights reserved. AMP32